Opioids can be effective in the right population, but there needs to be greater awareness among providers and health plans on which patients are not appropriate to start on opioids, said Elizabeth Stringer, PhD, chief science and clinical officer of axialHealthcare.
Opioids can be effective in the right population, but there needs to be greater awareness among providers and health plans on which patients are not appropriate to start on opioids, said Elizabeth Stringer, PhD, chief science and clinical officer of axialHealthcare.
Transcript
What are the intervention techniques that your clients have used that have been successful?
The opioid crisis in America continues to grow and evolve over time. One of the challenges is the diverse patient population that receive opioids. What we help the health plans do is general outreach and education to providers on who within the patient population is actually appropriate for opioid prescribing. So, a lot of the success that the plans has had early on is less on specific targeted patient populations of a very specific type and more just general education of providers of best practices.
One of the things, I think, the American public might not understand is that within the medical education, MDs receive very little training in pain management. Which is ironic, because pain is just a symptom that something is wrong with the body and it traverses all different specialties within medicine. It’s also the number 1 reason why patients go and see their doctors, is for a pain complaint. And we know that for a long time physicians were taught that when a patient does present with a pain complaint, if the patient is taking the opioids for the pain, that’s safe and low risk. What we have learned over time is that’s not exactly true. Opioids can be effective at treating pain in the acute setting for a specific part of the population with specific diagnoses.
A good example is that low back pain is kind of a number 1 complaint of patients with pain, but opioids are not indicated for patients with low back pain. So, raising the awareness, having the provider population understand who is appropriate to prescribe opioids to and at what levels we’re able to help the health plans have early success in getting opioids to the correct patients and avoiding opioid initiation where it’s not appropriate.
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More